Alteration of transforming growth factor-β1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 263-272

  Reisdorf, Philippe ^a   Lawrence, David A ^a   Sivan, Virginie ^a   Klising, Eve ^a   Martin, Michèle T ^a,b  

^a DIF   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD3 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; FIBROSIS; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN; SMOOTH MUSCLE; SWINE;

ANIMALS; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; FIBROBLASTS; FIBROSIS; MUSCLE, SMOOTH; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIGNAL TRANSDUCTION; SKIN; SMAD3 PROTEIN; SWINE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0035404387     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61692-6     Document Type: Article

References (38)

1. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts, I. Paracrine cells important in health and disease Am J Physiol 1999, 277:C1-C9
2. Serini G, Gabbiani G: Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999, 250:273-283
3. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66
4. Roberts AB, Sporn MB (eds): The transforming growth factor-βs. Peptide Growth Factors and Their Receptors, vol I. Berlin, Springer-Verlag, 1990, pp 419-472
5. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286-1292
6. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342:1350-1358
7. Bottinger EP, Kopp JB: Lessons from TGF-beta transgenic mice. Miner Electrolyte Metab 1998, 24:154-160
8. Martin M, Lefaix J, Delanian S: TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000, 47:277-290
9. Lawrence DA: Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996, 7:363-374
10. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111
11. Saltis J: TGF-beta: receptors and cell cycle arrest. Mol Cell Endocrinol 1996, 116:227-232
12. Massague J, Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000, 19:1745-1754
13. Piek E, Heldin CH, ten Dijke P: Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999, 13:2105-2124
14. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791
15. Derynck R, Zhang Y, Feng XH: Smads: transcriptional activators of TGF-beta responses. Cell 1998, 95:737-740
16. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM: Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998, 17:3091-3100
17. Nagarajan RP, Zhang J, Li W, Chen Y: Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 1999, 274:33412-33418
18. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP: Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 2000, 275:11320-11326
19. Dennler S, Huet S, Gauthier JM: A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999, 18:1643-1648
20. Labbe E, Silvestri C, Hoodless PA, Wrana JL, Attisano L: Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 1998, 2:109-120
21. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M. Heldin NE, Heldin CH, ten Dijke P: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997 389:631-635
22. Lefaix JL, Martin M, Tricaud Y, Daburon F: Muscular fibrosis induced after pig skin irradiation with single doses of 192Ir gamma-rays. Br J Radiol 1993, 66:537-544
23. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F: Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993, 134:63-70
24. Lefaix JL, Daburon F: Diagnosis of acute localized irradiation lesions: review of the French experimental experience. Health Phys 1998, 75:375-384
25. El Nabout R, Martin M, Remy J, Kern P, Robert L, Lafuma C: Collagen synthesis and deposition in cultured fibroblasts from subcutaneous radiation-induced fibrosis. Matrix 1989, 9:411-420
26. Wegrowski J: Fibronectin and glycosaminoglycan synthesis by fibrotic pig fibroblasts in primary culture. Connect Tissue Res 1989, 23:237-249
27. Vozenin-Brotons MC, Sivan V, Gault N, Renard C, Geffrotin C, Delanian S, Lefaix JL, Martin M: Antifibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med 2001, 30:30-42
28. Martin M, Remy J, Daburon F: Abnormal proliferation and aging of cultured fibroblasts from pigs with subcutaneous fibrosis induced by gamma irradiation. J Invest Dermatol 1989, 93:497-500
29. Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ: Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev 1998, 12:2102-2107
30. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989, 17:6419
31. Tasab M, Batten MR, Bulleid NJ: Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen. EMBO J 2000, 19:2204-2211
32. Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM, Lefaix JL: Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 1997, 15:981-989
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
34. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S: Participation of smad2, smad3, and smad4 in transforming growth factor beta (TGF-beta)-induced activation of smad7. J Biol Chem 2000, 275:29308-29317
35. McCaffrey TA: TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev 2000, 11:103-114
36. Roulot D, Sevcsik AM, Coste T, Strosberg AD, Marullo S: Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 1999, 29:1730-1738
37. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999, 1:260-266
38. Ashcroft GS, Roberts AB: Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 2000, 11:125-131